Fig. 1From: The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center studyThe mean percentage decrease in the rate of VOCs (event/patient/year) after the initiation of hydroxyurea among adults (≥18 yrs.) and pediatric population (< 18 yrs.)Back to article page